Clinical Trials · NCT06176365
A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 274
- Start date
- Jan 2024
- Locations
- 28 sites, Japan
- Primary endpoint
- Percentage change in body weight from baseline to Week 76